Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Endocrinology | Family Medicine
Search Medical Condition
Diabetes Mellitus, Type 1 Clinical Trials
A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (322) clinical trials
Do you have Type 1 Diabetes?
The INSTRIDE Studies are looking to see how well an investigational insulin works to control blood sugar levels. The investigational insulin has been designed to be as similar as possible to insulin glargine (Lantus®), which has helped many people with diabetes worldwide. The investigational insulin could be a more affordable ...
A 26-Week Randomized, Open-label, Active Controlled, Parallel-group, Study Assessing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin ± Pioglitazone, Followed by a Fixed Ratio Combination Single-arm 26-Week Extension Period
The maximum duration for GLP1-RA patients will be approximately 29 weeks: an up to 2 week screening period, a 26 week treatment period (either randomized or uncontrolled), and a 3 or 9 day post-treatment safety followup period. Maximum duration for FRC patients will be approximately 55 weeks: an up to ...
Go the distance: Get screened for risk of type 1 diabetes
Type 1 Diabetes TrialNet, an international network of researchers exploring ways to prevent and delay the progression of type 1 diabetes, is taking great strides for type 1 diabetes. When you get involved in TrialNet research, you become part of a worldwide team that is working to find a way ...
Diabetes Mellitus Types I and II
Rapid Medical Research is looking for Type 1 or Type 2 Diabetics to take part in a research study.
Diabetic Neuropathy in Type 1 and 2 Diabetics
Northern California Research is conducting a study for diabetic peripheral neuropathy (DPN). DPN is a type of nerve damage that can occur if you have diabetes. This study is for men and women who are experiencing painful diabetic peripheral neuropathy in both lower extremities (legs). The specific events that result ...
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
Primary objective: To demonstrate that morning injection of Toujeo compared to Lantus will provide better glycemic control evaluated by Continuous Glucose Monitoring (CGM) in adult patients with type 1 diabetes mellitus. Secondary objective(s): To demonstrate that treatment with Toujeo compared to Lantus will provide lower incidence rate of nocturnal symptomatic ...
Type 1 and Type 2 Diabetes - Smartphone App Study
A research study is evaluating a Smartphone app for people with Type 1 or Type 2 Diabetes. This study is examining the ACCU-CHEK® Connect Diabetes Management System to learn whether this system improves treatment satisfaction in patients with type 1 and type 2 diabetes.
Natural History Study of the Development of Type 1 Diabetes
To perform baseline and repeat assessments over time of the metabolic and immunologic status of individuals at risk for type 1 diabetes to characterize their risk for developing T1D and identify subjects eligible for prevention trials, describe the pathogenic evolution of T1D, and increase the understanding of the pathogenic factors ...
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of LX-4211 as Adjunct Therapy in Adult Patients with Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control
Evaluate LX4211 in type 1 patients with poorly controlled blood sugars.
Preserving Beta-Cell Function with Tocilizumab in New Onset Type 1 Diabetes (the EXTEND Study)
The healthy insulin-producing beta cells that you have left when you are first diagnosed with type 1 diabetes are precious. The aim of the EXTEND Study is to test whether a therapy called tocilizumab (Actemra®) can stop the immune system from attacking these remaining beta cells and possibly extend the ...
